Decentralised clinical trials

Craig Stevens, Senior Patient Engagement Specialist, and Amanda Henkel, VP, Strategy from MEDiSTRAVA (an Inizio Company), delve into the challenges and opportunities that surround clinical trial design for rare diseases. The drug development process requires collaboration at all stages, and is particularly important in the rare disease setting, where in addition to pharmaceutical industry stakeholders, […]

LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The partnership will operate under the acronym of PACE, reflecting the requirement to move quickly to address today’s clinical development challenges. It also represents the values of Passion, Agility, Communication and Excellence in delivery. […]

Tom Brazier, Director, Decentralised Clinical Solutions, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. Hybrid and decentralised clinical trials (DCTs) are fast becoming the norm, but they often involve multiple vendors and service providers, presenting sponsors and CROs […]

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.   Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly and is now valued at $7.8 billion with […]

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The findings from the research indicate […]

Clinical trial support organisation Medical Research Network (MRN) has won a Queen’s Award for Enterprise for International Trade for its work in helping enhance the delivery of clinical trials through decentralisation technology.  The Queen’s Awards   Established in 1965, The Queen’s Awards for Enterprise are the most prestigious business awards in the UK. They celebrate the success […]

 A fully integrated patient-centric platform has been launched to help optimise the management of hybrid and decentralised clinical trials (DCT).    The platform   The platform, developed by Kayentis, has been designed to help clinical trials providers overcome the logistical hurdles faced when bringing trials to patients’ homes, whilst also improving how patients and sites use DCT […]

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and patients can (and will) be […]